Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine

Melanoma has a high degree of malignancy and mortality. While there are some hopeful clinical trials for melanoma treatment in progress, they have not yet to yield significant long-term cure rates. Cancer vaccines including mRNA are currently one of the most promising strategy for tumor immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ping, Haiqin, Yu, Wenjun, Gong, Xiaoming, Tong, Xin, Lin, Cheyu, Chen, Zhaojun, Cai, Caiyun, Guo, Kai, Ke, Hengning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375085/
https://www.ncbi.nlm.nih.gov/pubmed/35962880
http://dx.doi.org/10.1007/s10637-022-01290-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375085/
https://www.ncbi.nlm.nih.gov/pubmed/35962880
http://dx.doi.org/10.1007/s10637-022-01290-y

Ejemplares similares